NYSE ARCA | ETF
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
RARE | Ultragenyx | Healthcare | Biotechnology | 4% |
BGNE | BeiGene Ltd | Healthcare | Biotechnology | 3.71% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.68% |
QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 3.65% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.64% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 3.56% |
IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.55% |
EXEL | Exelixis Inc | Healthcare | Biotechnology | 3.49% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.46% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.46% |
UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.43% |
ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.41% |
CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 3.41% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 3.41% |
IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.37% |
HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 3.36% |
CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.35% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.35% |
TECH | Bio-Techne Corp | Healthcare | Biotechnology | 3.35% |
ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.34% |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.